Interleukin-1 Blockade in Recently Decompensated Heart Failure
Status:
Completed
Trial end date:
2016-09-23
Target enrollment:
Participant gender:
Summary
The RED-HART is a randomized double-blinded placebo-controlled study of Anakinra (IL-1
blocker) in patients with recently decompensated heart failure to determine the safety and
efficacy in terms of aerobic exercise capacity and ventilatory efficiency measured with a
cardiopulmonary exercise test.